| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/24/2006 | WO2006086978A2 Use of deuterated n-[2-(5-methoxy-1h-indol-3-yl)-ethyl]acetamides and the pharmaceutically acceptable salts thereof, and medicaments containing said compounds |
| 08/24/2006 | WO2006086923A1 4-hydroxy pentanamides, the preparation and use thereof |
| 08/24/2006 | WO2006086870A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 08/24/2006 | WO2006040149A9 Heterocyclic ketone compounds for treating alzheimer’s disease |
| 08/24/2006 | WO2005116002B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060189673 Phenylazole compound, production process therefor and antioxidant |
| 08/24/2006 | US20060189666 Alzheimer's disease; bridged bicycloalkyl sulphonamide and sulphamide derivatives; [9-endo]2',3', 4',5'-Tetrahydro-5'-(2.2.2-trifluoroethyl)spiro[3-{(E)-2-[5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yl]ethenyl}-4-methyl bicyclo[4.2.1]non-3-ene]-9,3'-[1,2,5]thiadiazol-1',1'-dioxide |
| 08/24/2006 | US20060189664 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 08/24/2006 | US20060189663 Pyrrole-2,5-dithione derivatives as liver x receptor modulators |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189625 Cyclic aminophenyl sulfamate derivative |
| 08/24/2006 | US20060189589 For therapy of Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease |
| 08/24/2006 | US20060189578 Method for the synthesis of compounds of formula I and their uses thereof |
| 08/24/2006 | US20060189483 Metal-containing compositions, preparations and uses |
| 08/24/2006 | US20060188525 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin |
| 08/24/2006 | US20060188512 Active immunization to generate antibodies to solble a-beta |
| 08/24/2006 | US20060188484 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188483 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | DE202006002547U1 Combination, useful for preventing short term memory loss, confusion disease and Alzheimer's dementia, comprises potassium, alkaloids and medicament water |
| 08/24/2006 | DE102005008312A1 Verwendung deuterierter N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]acatamide und deren pharmazeutisch verträglicher Salze sowie diese Verbindungen enthaltende Arzneimittel Using deuterated N- [2- (5-methoxy-1H-indol-3-yl) -ethyl] acatamide and their pharmaceutically acceptable salts as well as medicaments containing these compounds |
| 08/24/2006 | DE102005007304A1 Triazolderivate Triazole derivatives |
| 08/24/2006 | CA2598484A1 Inhibition or treatment of dyskinesia |
| 08/24/2006 | CA2598407A1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using them |
| 08/24/2006 | CA2598080A1 Amyloid-binding peptides, analogues and uses thereof |
| 08/24/2006 | CA2597958A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 08/24/2006 | CA2597910A1 Dosage form and method for sustained release of a substituted pyrazine compound |
| 08/24/2006 | CA2597622A1 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | CA2597620A1 Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | CA2597616A1 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 08/24/2006 | CA2597594A1 Azolylacylguanidines as beta-secretase inhibitors |
| 08/24/2006 | CA2595368A1 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
| 08/24/2006 | CA2595269A1 Composition comprising ocaperidone |
| 08/24/2006 | CA2572151A1 Oligonucleotides comprising a non-phosphate backbone linkage |
| 08/23/2006 | EP1693456A1 Gene encoding g protein-coupled receptor and gene product thereof |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693367A1 Piperidine compound and method for producing same |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1693061A1 Use of 4-aminoderivatives for the preparation of a medicament for treating neurological diseases |
| 08/23/2006 | EP1693060A1 Therapeutic or preventive agents for ischemic neuropathy |
| 08/23/2006 | EP1692273A1 Melanocytes in therapy of neurodegenerative diseases |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692143A1 Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease |
| 08/23/2006 | EP1692129A1 Keto lactam compounds and use thereof |
| 08/23/2006 | EP1692114A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 08/23/2006 | EP1692109A2 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 08/23/2006 | EP1692099A1 Somatostatine receptor subtype 1 (sstr1) active compounds and their use in therapy |
| 08/23/2006 | EP1692096A1 Hydroxylamine derivatives |
| 08/23/2006 | EP1691892A2 Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same |
| 08/23/2006 | EP1691835A1 Methods of treating chronic pain using compositions that specifically bind cd11d (alpha-d) integrin |
| 08/23/2006 | EP1691814A2 Anti-inflammatory agents |
| 08/23/2006 | EP1691800A1 Methods and agents for inhibiting dynamin-dependent endocytosis |
| 08/23/2006 | EP1633346B1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid|- 2- (phenyl)- amid| derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1368358B1 Isoxazoline derivatives as anti-depressants |
| 08/23/2006 | EP1363920B1 Modified psma ligands and uses related thereto |
| 08/23/2006 | EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/23/2006 | EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist |
| 08/23/2006 | EP1276867B1 Use of human latrophilin-like G protein-coupled receptor in screening methods |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1240344B1 Replication incompetent herpes viruses for use in gene therapy |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1146870B1 Antioxidant compositions for companion animals |
| 08/23/2006 | EP0998916B1 Medicinal compositions for application to mucosa |
| 08/23/2006 | CN1823161A Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regenaration |
| 08/23/2006 | CN1823068A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/23/2006 | CN1823064A 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
| 08/23/2006 | CN1823062A Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 08/23/2006 | CN1823061A Pyrrole-2, 5-dione derivatives as liver X receptor modulators |
| 08/23/2006 | CN1823054A Imidazole derivatives ó¾ |
| 08/23/2006 | CN1823048A Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands |
| 08/23/2006 | CN1823040A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 08/23/2006 | CN1823039A Cyclic aminophenyl sulfamate derivative |
| 08/23/2006 | CN1823036A Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 08/23/2006 | CN1822845A Means for preventing and treating cellular death and their biological applications |
| 08/23/2006 | CN1822842A Solid pharmaceutical preparation |
| 08/23/2006 | CN1822837A 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts |
| 08/23/2006 | CN1822836A Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor |
| 08/23/2006 | CN1822828A Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 08/23/2006 | CN1822825A Treatment of anxiety disorders |
| 08/23/2006 | CN1822819A Oral controlled release forms useful for reducing or preventing nicotine cravings |
| 08/23/2006 | CN1821256A I*-salidroside and its preparation and use in anti-senile dimentia medicine |
| 08/23/2006 | CN1821249A Crystal-free type Idi prone and its preparing method |
| 08/23/2006 | CN1821243A Substituted pyridine M receptor excitomotor, its preparing process and its use |
| 08/23/2006 | CN1820756A Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 08/23/2006 | CN1820738A Tramadol hydrochloride slow release dripping pill and its preparing method |
| 08/23/2006 | CN1820666A Functional cigarette for giving up smoking and its producing method |
| 08/23/2006 | CN1820646A Health food containing paederia scandens |
| 08/23/2006 | CN1820645A Danshi food and preparing method |
| 08/23/2006 | CN1271083C Composition, extraction process and use of total triterpene sapogenin extracted from bamboo |
| 08/23/2006 | CN1271070C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
| 08/23/2006 | CN1271052C Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 08/23/2006 | CN1270777C Addition agent of pyrithioxine hydrochloride utilized for injection |
| 08/23/2006 | CN1270727C Therapeutic agents for curing injured spinal cord |
| 08/23/2006 | CN1270718C Epiallopregnanolone in the treatment of CNS disorders |
| 08/23/2006 | CN1270717C Galantamin sustained release preparation and preparing process |
| 08/23/2006 | CN1270714C Microemulsion preconcentrates containing piperidine substance P antagonist |